Pal Pal SK SK Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations Cancer Discov Cancer Discov 2018 2018 8 8 812 812 821 821 supplied-pmid 29848605? Here, FGFR3 is linked to urothelial carcinoma.